TONS of Vitamin C Arrive in Wuhan China

We can all agree that 50 tons of vitamin C pretty much qualifies as a megadose. We can also likely agree that trucking 50 tons of vitamin C, straight into Wuhan, full in the face of the COVID-19 epidemic, qualifies as news. The news media are not reporting this, or any other, significantly positive megavitamin news. We are so used to being lied to that the truth is like a diamond in a five-and-dime store: you can't believe it is real because it is mixed in with the fakes. News of nutrition-centered treatment of COVID-19 has been branded "fake news" and "false information." I say that what is "false" and "fake" is the deliberate omission of any news of health-saving, life-saving measures already underway to help the people of China and the rest of our planet.

More Vitamin C Studies Approved in China to Fight Coronavirus: Therapy Censored in U.S.

On January 27, 2020 we published a press release from Orthomolecular Medicine News Service regarding Vitamin C and its use in treating the Coronavirus. It soon went viral on Facebook, until Facebook labeled it as "Fake News." Facebook partners with a website called "Lead Stories" to discredit news stories they do not want becoming popular on Facebook. Health Impact News is a popular target of "Lead Stories." Since we published this news release in January, however, several hospitals in China have begun to conduct trials on intravenous Vitamin C therapy, so it is hardly "Fake News" as Facebook is claiming. In fact, Facebook is the one guilty of promoting "Fake News" by erroneously claiming there is no proof that Vitamin C can help combat the Coronavirus, when in fact clinical research trials are well underway in China with ample evidence that should be shared with the public, and not suppressed, simply because U.S. sources in bed with Big Pharma do not want the public to have this information. Orthomolecular Medicine News Service editor Andrew Saul has just published an updated report, and he notes: "The World Health Organization (WHO) has, literally, met with Google and Facebook and other media giants to stop the spread of what they declare to be wrong information. Physician-directed, hospital-based administration of intravenous vitamin C has been marginalized or discredited. Scientific debate over COVID-19 appears to not be allowed. Ironically, Facebook, blocking any significant users' sharing of the news of approved vitamin therapy research, is itself blocked in China by the Chinese government. As for the internet, yes, China has it. And yes, it is censored. But, significantly, the Chinese government has not blocked this real news on how intravenous vitamin C will save lives in the COVID-19 epidemic." Hence, the news about Vitamin C therapy helping with the Coronavirus outbreak is found mostly in Chinese language websites, endorsed by the Communist China Government's controlled media, but mostly banned in the English language social media platforms like Facebook, or censored from Google search results.

Gardasil HPV Vaccine Acceptance into China Creates Instant Billionaires

Last month (May, 2018) we published a report from the vaccine marketing trade publication, Fierce Pharma, that Merck's sales this year were beating financial forecasts, primarily due to its entrance into the China market for its top-selling Gardasil HPV vaccine. Fierce Pharma reported at that time that the Gardasil vaccine was fast-tracked for approval into the China market: "Late last month, the Chinese FDA granted Gardasil 9 a conditional approval only nine days into a review." Now, Fierce Pharma is reporting that Gardasil's acceptance into the China market has produced instant billionaires.

As Merck’s Gardasil U.S. Sales Decline Profits Continue to Increase as Vaccine is Launched in China

The pharmaceutical marketing trade publication, Fierce Pharma, announced this month (May 2018) that Merck has beat Wall Street expectations for their Gardasil vaccine sales during the first quarter of 2018, achieving 24% growth with $660 million for the HPV vaccine. The report notes that sales in the U.S. are declining, attributing the decline in sales to the CDC decision to reduce their recommendation of the Gardasil vaccine to be only two doses, instead of three. Nothing is mentioned about declining public opinion regarding Gardasil, nor the numerous lawsuits against the company outside the U.S. The increase in sales for Gardasil is attributed to their entrance into the China market. The original vaccine won Chinese approval last year, while late last month the Chinese FDA granted Gardasil 9 a conditional approval only nine days into a review.

HPV Vaccines in China: What constitutes a Trade Secret?

Why did citizens of China have to petition their government for access to clinical trial data currently available via multiple national and international government sponsored internet sites? Why is information regarding HPV vaccines which is open for public view throughout most of the world deemed a ‘trade secret’ in China? These questions are particularly relevant when you consider the heated controversy surrounding HPV vaccination programs in so many countries around the world. Is it possible that Director Bi Jing-quan, leader of China’s State Bureau of Food & Drug Administration knows information contained in clinical trial data would reveal substantial safety concerns surrounding HPV vaccines? Does Director Bi Jing-quan think the citizens of China would be eager to use HPV vaccines if they knew the true rate of adverse events is not known because no inert placebos were used during clinical trials? Is that one of the reasons HPV vaccine clinical trial data is a ‘trade secret’ in China?

Dr. Sin Hang Lee recommends China postpone HPV vaccinations

China’s population consists of approximately 143 million females age 9-25. If human papillomavirus (HPV) vaccine manufacturers can convince the Chinese government to vaccinate every woman in this age group with 3 doses of HPV vaccine via a Publicly Funded Program as proposed by two of their paid consultants, the revenue generated could amount to over $64 billion USD (using price of HPV vaccines sold in the USA at $150/dose). This staggering amount of money would provide an enormous impact to their bottom line. But the question is at what cost?

Why Are Babies Dying in China After Receiving the Hepatitis B Vaccine?

At least nine babies have died in China the past few weeks after being injected with the Hepatitis B vaccine. The deaths, which have occurred within a very short time after receiving the vaccine, are gaining wide exposure in the China media. Because vaccines are almost always promoted as safe, injuries and deaths often are not associated with the vaccine, so there may be more deaths than have currently been reported. One of the deaths was reported by a family member after hearing about other babies dying shortly after receiving the vaccine in the media. When the family originally was fighting to save the baby from dying, they had not suspected the vaccine. Reaction in the media and the medical community in China is in stark contrast to how news like this is often reported in the U.S., where the mainstream media is reluctant to report any negative news regarding vaccines, and most doctors refuse to even acknowledge the risks vaccines carry. Here are some quotes from the China media: "Doctors also warn that the hepatitis B vaccine is not suitable for all newborns. Those suffering from fever, weak immune system, low birth weight or serious eczema should not be given the vaccination." "As the investigation continues, medical experts are reminding parents that infants don’t need to receive hepatitis B vaccines immediately after being born. They say it’s ok for parents to wait until the investigation results come out, before deciding whether they want to use the vaccines or not." In the U.S., one never reads any cautionary advice like this, in spite of the fact that deaths and serious adverse reactions do occur often.